High-Dose Interferon alfa-2b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for High-Dose Interferon alfa-2b, covering 2016-10-17 to 2016-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma [Phase 2]